The Ludwig Boltzmann Institute of Osteology (LBIO) was founded in 1991 through a partnership agreement between Austrian Workers’ Compensation Board (AUVA), Vienna Health Insurance Fund (WGKK) – now Austrian Social Health Insurance Fund (OEGK) and Ludwig Boltzmann Gesellschaft (LBG) at the Hanusch Hospital and the Trauma Centre Meidling, with Prof Klaus Klaushofer, MD, serving as the Scientific and Administrative Head until the end of 2018. As from 1 January 2019, he was succeeded by Assoc.Prof Jochen Zwerina, MD. A Board oversees the scientific and administrative activities of the LBIO with Board members representing the partner institutions (AUVA, OEGK, LBG). Special emphasis was placed on the organisation and performance of multidisciplinary basic and clinical research in bone and mineral metabolism with the main focus on translational medicine. Thus, the LBIO serves as the scientific core centre within a multidisciplinary clinical network located at the two hospitals targeting diagnosis and treatment of bone and joint diseases.
The LBIO is headed by Jochen Zwerina. Furthermore, the institute is adviced by an Orthopaedics and Traumatology Consultant (Roland Frank) as well as a Basic Science Consultant (Peter Fratzl). Internally the institute is structured in 3 Program Lines (PLs) and 3 Support Facilities (SFs). PL1 (Material Science – Organic Matrix headed by Eleftherios Paschalis) and PL3 (Clinical Science headed by Roland Kocijan) are located at the Hanusch Hospital, while PL2 (Material Science – Mineral, Structure, Function headed by Markus Hartmann) is located at the Trauma Centre Meidling. SF1 (Cell Biology headed by Thomas Dechat) and SF2 (Biostatistics headed by Martina Behanova) are also located at the Hanusch Hospital. SF3 (microcomputed tomography headed by Stéphane Blouin) is a shared device with the Ludwig Boltzmann Institute of Traumatology and is located at the Lorenz Böhler Trauma Centre in Vienna.